EGFR and adenoma: Mechanistically, it has been reported that heterozygous deletion of ATG5 activated EGFR and Wnt/β–catenin pathways in adenomas of Apc(Min/+) mice leading to the enhancement of the IFN γ-dependent inhibition of these pathways [43].